TRANSITION SERVICES AGREEMENTTransition Services Agreement • October 2nd, 2020 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledOctober 2nd, 2020 Company Industry JurisdictionTHIS TRANSITION SERVICES AGREEMENT (this “Agreement”) is made and entered into as of September 30, 2020, by and between PDL BioPharma, Inc., a Delaware corporation (“PDL”) and LENSAR, Inc., a Delaware corporation (“LENSAR”). PDL and LENSAR are referred to herein individually as a “Party”, and collectively as the “Parties.”
TRANSITION SERVICES AGREEMENTTransition Services Agreement • October 2nd, 2020 • LENSAR, Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledOctober 2nd, 2020 Company Industry JurisdictionTHIS TRANSITION SERVICES AGREEMENT (this “Agreement”) is made and entered into as of September 30, 2020, by and between PDL BioPharma, Inc., a Delaware corporation (“PDL”) and LENSAR, Inc., a Delaware corporation (“LENSAR”). PDL and LENSAR are referred to herein individually as a “Party”, and collectively as the “Parties.”
TRANSITION SERVICES AGREEMENTTransition Services Agreement • August 26th, 2020 • LENSAR, Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledAugust 26th, 2020 Company Industry JurisdictionTHIS TRANSITION SERVICES AGREEMENT (this “Agreement”) is made and entered into as of , 2020, by and between PDL BioPharma, Inc., a Delaware corporation (“PDL”) and LENSAR, Inc., a Delaware corporation (“LENSAR”). PDL and LENSAR are referred to herein individually as a “Party”, and collectively as the “Parties.”